Bitolterol
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (RS)-[4-(1-Hydroxy-2-tert-butylamino-ethyl)- 2-(4-methylbenzoyl)oxy-phenyl] 4-methylbenzoate | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a601236 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 30392-41-7 |
| ATC code | R03AC17 |
| PubChem | CID 35330 |
| DrugBank | APRD00827 |
| ChemSpider | 32525 |
| UNII | 9KY0QXD6LI  |
| ChEMBL | CHEMBL1201295 |
| Chemical data | |
| Formula | C28H31NO5 |
| Mol. mass | 461.549 g/mol |
| SMILES | eMolecules & PubChem |
Bitolterol mesylate (Tornalate) is a β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and COPD.
Bitolterol has a rapid onset of action (2–5 minutes) and may last up to 6–8 hours.
Bitolterol was withdrawn from the market by Élan Pharmaceuticals in 2001.
|
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
